New 52 Week Low Today

Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 7:53 PM EDT

44.24

+0.03 (+0.07%)

Volume

236,145

44.21

+0.27 (+0.61%)

Volume

12,978,521

52 week range

43.73 - 69.10

Open43.97
Day High44.47
Day Low43.73
Prev Close43.94
52 Week High69.10
52 Week High Date05/11/23
52 Week Low43.73
52 Week Low Date05/01/24

Key Stats

Market Cap89.603B
Shares Out2.03B
10 Day Average Volume16.66M
Dividend2.40
Dividend Yield5.43%
Beta0.44
YTD % Change-13.84

KEY STATS

Open43.97
Day High44.47
Day Low43.73
Prev Close43.94
52 Week High69.10
52 Week High Date05/11/23
52 Week Low43.73
52 Week Low Date05/01/24
Market Cap89.603B
Shares Out2.03B
10 Day Average Volume16.66M
Dividend2.40
Dividend Yield5.43%
Beta0.44
YTD % Change-13.84

RATIOS/PROFITABILITY

EPS (TTM)-3.10
P/E (TTM)-14.25
Fwd P/E (NTM)74.55
EBITDA (TTM)20.391B
ROE (TTM)-25.45%
Revenue (TTM)45.534B
Gross Margin (TTM)75.94%
Net Margin (TTM)-13.47%
Debt To Equity (MRQ)337.64%

EVENTS

Earnings Date07/26/2024(est)
Ex Div Date04/04/2024
Div Amount0.60
Split Date-
Split Factor-

Latest On Bristol-Myers Squibb Co

J&J, Bristol Myers Squibb lose challenges to Medicare drug-price negotiationsApril 29, 2024CNBC.com
Cramer: 5 sectors of the market that are working and stocks that stand out in eachApril 28, 2024CNBC.com
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly lossApril 25, 2024CNBC.com
It’s the busiest week in earnings and these stocks could see a blow upApril 24, 2024CNBC.com
5 things to know before the stock market opens MondayApril 22, 2024CNBC.com

Content From Our Affiliates

FTC expands patent listing challenges for drugsApril 30, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Bristol-Myers Squibb (BMY) and Laboratory (LH)April 30, 2024TipRanks
Analysts Are Bullish on These Healthcare Stocks: Atricure (ATRC), Alkermes (ALKS)April 29, 2024TipRanks
Bristol Myers price target lowered to $55 from $60 at BofAApril 26, 2024TipRanks
Bristol Myers announces EMA’s CHMP recommended approval of OpdivoApril 26, 2024TipRanks

Profile

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric...

Christopher Boerner Ph.D.

Chairman of the Board, Chief Executive Officer, Chief Operating Officer

David Elkins

Executive Vice President, Chief Financial Officer, Member of the Leadership Team

Cari Gallman

Executive Vice President, Corporate Affairs, Member of the Leadership Team

Sandra Leung

Executive Vice President, General Counsel, Member of the Leadership Team

Adam Lenkowsky

Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team

Address

Route 206 And Province Line Road

Princeton, NJ

08543

United States

https://www.bms.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
GSK GSK plc	42.57	+1.13	+2.73%
SNY Sanofi SA	50.03	+0.80	+1.63%
GILD Gilead Sciences Inc	65.51	+0.31	+0.48%
PFE Pfizer Inc	27.18	+1.56	+6.09%
AMGN Amgen Inc	277.37	+3.43	+1.25%